Govindarajulu Manoj, Ramesh Sindhu, Shankar Tharanth, Kora Murali Krishna, Moore Timothy, Dhanasekaran Muralikrishnan
Department of Drug Discovery and Development, Auburn University Harrison School of Pharmacy, Auburn, AL 36849, USA.
Department of Internal Medicine, Ramaiah Medical College and Hospital, Bengaluru 560054, Karnataka, India.
NeuroSci. 2022 Sep 27;3(4):533-545. doi: 10.3390/neurosci3040038. eCollection 2022 Dec.
Neurodegenerative diseases are characterized by progressive loss of neurons in specific regions of the brain. Neuronal death is often associated with the accumulation of misfolded proteins due to genetic mutations or abnormal protein homeostasis. An essential mechanism for regulating the clearance of misfolded proteins is neddylation, a post-translational modification closely related to ubiquitination. Neddylation is brought about by conjugating neural precursor cell-expressed developmentally downregulated protein 8 (NEDD8) to target substrates through a cascade of cellular events. Neddylation is crucial for many biological processes, and dysfunctional neddylation is implicated in several neurodegenerative diseases. This review discusses the current understanding of the role of neddylation pathways in neurodegenerative disorders and the emergence of neddylation signaling as a potential target for drug discovery and development in neurodegenerative diseases.
神经退行性疾病的特征是大脑特定区域的神经元逐渐丧失。由于基因突变或蛋白质稳态异常,神经元死亡通常与错误折叠蛋白的积累有关。调节错误折叠蛋白清除的一个重要机制是NEDDylation,这是一种与泛素化密切相关的翻译后修饰。NEDDylation是通过一系列细胞事件将神经前体细胞表达的发育下调蛋白8(NEDD8)与靶底物结合而实现的。NEDDylation对许多生物学过程至关重要,功能失调的NEDDylation与几种神经退行性疾病有关。本文综述了目前对NEDDylation途径在神经退行性疾病中的作用的理解,以及NEDDylation信号作为神经退行性疾病药物发现和开发潜在靶点的出现。